YouCongress
Explore About Sign up

Comment by Nicholas Wade

Human avatar
Science writer; former New York Times science editor
Second, the early cases are clustered round the market not because that was their origin but because the Chinese authorities, believing they had a repeat of the SARS1 epidemic on their hands, made closeness to the market a criterion for recognizing victims of the new disease.
AI Verified (Mar 8, 2023)
Source:
Nicholas Wade, written testimony before the House Select Subcommittee on the Coronavirus Pandemic, March 8, 2023.
Like Share on X 2mo ago

Policy proposals and claims

The clustering of early cases around the Huanan market reflects where the COVID-19 virus emerged, not just where testing looked
votes Against
Statement relation verification history AI Verified Report this

Statement relation comments

AI Verified Wade directly addresses early-case clustering and says it resulted from recognition criteria around the market rather than origin, so the linked statement stance is determinable. · Hector Perez Arenas gpt-5-codex · 2mo ago
Vote inference verification history AI Verified Report this

Vote answer comments

AI Verified Correct answer is against: Wade says the early cases clustered near the market because of ascertainment/recognition criteria, not because the market was their origin. · Hector Perez Arenas gpt-5-codex · 2mo ago

Quote authenticity verification history

Report this

Quote authenticity comments

AI Verified House Oversight PDF identifies Nicholas Wade's March 8, 2023 testimony and contains the stored passage saying market clustering reflected case-recognition criteria, not origin. · Hector Perez Arenas gpt-5-codex · 2mo ago
replying to Nicholas Wade

Other opinions from Nicholas Wade

See all

Other authors to follow

Jonathan Jonathan Rootclaim blog author Andrew T. Levin Andrew T. Levin Economist, Professor at Dartmouth College and NBER Research Associate Scott Alexander Scott Alexander Author and psychiatrist OpenAI OpenAI AI research organization Yoshua Bengio Yoshua Bengio AI Pioneer, Turing Award winner Demis Hassabis Demis Hassabis Nobel laureate, AI Researcher and CEO of DeepMind Richard H. Ebright Richard H. Ebright Molecular biologist, Rutgers University; Board of Governors Professor of Chemistry and Chemical Biology Anthropic Anthropic AI safety research company Michael B. Weissman Michael B. Weissman Physicist, Professor Emeritus at the University of Illinois